Minerva Neurosciences NERV
NASDAQ NERV
$2.44 -0.19 (-6.99%)
As of: Nov 10, 2026 · 3:14 PM EST

Minerva Neurosciences (NERV) Operating Leases (2019 - 2020)

Updated

Minerva Neurosciences (NERV) recorded Operating Leases of $16,288 in Q2 2020, down 91.9% from $201,066 a year earlier and down 74.7% from the prior quarter.

Analysis

Minerva Neurosciences (NERV) Operating Leases (2019 - 2020) Analysis & Trends

At the end of FY2019, Minerva Neurosciences reported Operating Leases of $111,229.

  • Per Business Quant, the preceding three quarters came in at $64,350 (Q1 2020), $111,229 (Q4 2019) and $156,956 (Q3 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Minerva Neurosciences 121.62 Mn -126.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 16,288.00
Mar 31, 2020 64,350.00
Dec 31, 2019 111,229.00
Sep 30, 2019 156,956.00
Jun 30, 2019 201,066.00
Mar 31, 2019 243,115.00
API Access

Minerva Neurosciences Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=NERV&period=max&api_key=YOUR_API_KEY